Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Brandi

Showing results (51-60 of 246) with videos related to

Pageof 25
Sort By:
Cancer Genomics & Proteomics|August 30, 2020
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future PerspectivesAlessandro Rizzo, Angela Dalia Ricci, Simona Tavolari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Activated NF-kB in colorectal cancer: predictive or prognostic factor?Giovanni Brandi, Maria A Pantaleo, Guido Biasco, et al.
Expert Review of Gastroenterology & Hepatology|September 23, 2021
Toward personalized therapy for cholangiocarcinoma: new insights and challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Oncotarget|July 6, 2015
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesGiovanni Brandi, Andrea Farioli, Annalisa Astolfi, et al.
Expert Review of Gastroenterology & Hepatology|August 25, 2021
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
International Journal of Molecular Sciences|July 14, 2023
Improvements in Systemic Therapies for Advanced Malignant MesotheliomaChiara Deiana, Francesca Fabbri, Simona Tavolari, et al.
Critical Reviews in Oncology/Hematology|September 30, 2023
Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statementLorenza Rimassa, Giovanni Brandi, Monica Niger, et al.
Expert Review of Gastroenterology & Hepatology|August 27, 2021
Radiofrequency ablation for intrahepatic cholangiocarcinoma: a tool upon the path of integrative modalities?Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Future Oncology (London, England)|January 17, 2019
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issueVincenzo Di Nunno, Giorgio Frega, Lidia Gatto, et al.
Expert Review of Gastroenterology & Hepatology|March 18, 2022
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, et al.
Pageof 25

Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Cancer Genomics & Proteomics|August 30, 2020
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future PerspectivesAlessandro Rizzo, Angela Dalia Ricci, Simona Tavolari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Activated NF-kB in colorectal cancer: predictive or prognostic factor?Giovanni Brandi, Maria A Pantaleo, Guido Biasco, et al.
Expert Review of Gastroenterology & Hepatology|September 23, 2021
Toward personalized therapy for cholangiocarcinoma: new insights and challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Oncotarget|July 6, 2015
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesGiovanni Brandi, Andrea Farioli, Annalisa Astolfi, et al.
Expert Review of Gastroenterology & Hepatology|August 25, 2021
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
International Journal of Molecular Sciences|July 14, 2023
Improvements in Systemic Therapies for Advanced Malignant MesotheliomaChiara Deiana, Francesca Fabbri, Simona Tavolari, et al.
Critical Reviews in Oncology/Hematology|September 30, 2023
Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statementLorenza Rimassa, Giovanni Brandi, Monica Niger, et al.
Expert Review of Gastroenterology & Hepatology|August 27, 2021
Radiofrequency ablation for intrahepatic cholangiocarcinoma: a tool upon the path of integrative modalities?Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Future Oncology (London, England)|January 17, 2019
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issueVincenzo Di Nunno, Giorgio Frega, Lidia Gatto, et al.
Expert Review of Gastroenterology & Hepatology|March 18, 2022
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, et al.
Pageof 25